Lobby organisation
Organon & Co
Business / industry · Health & pharma · HQ: United States · Transparency Register entry
As of 9 September 2026, Organon & Co appears in 7 declared MEP meetings (5 different MEPs), most often with European People's Party.
In their own words
“Organon is a biopharmaceutical company. We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma. And we bring these important therapies around the world, with an international footprint that serves people in more than 140 markets.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 7 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2023–2026. Bar length is relative to its busiest year (4 in 2025).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 7 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 6 Feb 2026 | Andreas Glück | MDR/IVDR Revision |
| 27 Jan 2026 | Nicolás González Casares | Women's Health |
| 25 Nov 2025 | Nicolás González Casares | Pharmaceutical legislation |
| 12 Nov 2025 | Tomislav Sokol | Health Policy |
| 5 Sep 2025 | Elena Nevado del Campo | Introduction |
| 20 Jun 2025 | Elena Nevado del Campo | Introduction |
| 7 Feb 2023 | Maria Noichl | Women's health needs |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.